SpringerLink
Log in

Association between the P53 codon 72 polymorphism and nasopharyngeal cancer risk

  • Research Article
  • Published:
Tumor Biology

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

The P53 codon 72 polymorphism has been identified as a critical biomarker in modifying the risk of nasopharyngeal cancer (NPC). Many studies have investigated the association between the polymorphism of P53 codon 72 and NPC risk; however, the findings across the published studies are inconsistent and inconclusive. To acquire a more precise assessment for this association, we conducted an updated meta-analysis. The PubMed, Embase, Web of Science, and Wanfang databases were searched for relevant case–control studies. Totally, seven independent publications with 1,133 cases and 1,678 controls were retrieved. The pooled odds ratio (OR) with corresponding 95 % confidence interval (95 % CI) was calculated. Increased risk of NPC was observed among individuals carrying the variant allele and genotypes of P53 codon 72 (OR Pro vs. Arg = 1.32, 95 % CI 1.18–1.47, P OR < 0.001; OR ProPro vs. ArgArg = 1.90, 95 % CI 1.51–2.39, P OR < 0.001; OR ProArg + ProPro vs. ArgArg = 1.33, 95 % CI 1.13–1.57, P OR = 0.001; OR ProPro vs. ArgArg + ProArg = 1.65, 95 % CI 1.35–2.01, P OR < 0.001). Stratified analyses by ethnicity and source of controls also identified this significant relationship in Asians, Caucasians, and hospital-based case–control studies. There was no publication bias risk in our study. The updated meta-analysis supports the evidence that the polymorphism of P53 codon 72 is a risk factor for the development of NPC among the populations of both Asian and Caucasian.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Guigay J. Advances in nasopharyngeal carcinoma. Curr Opin Oncol. 2008;20:264–9.

    Article  PubMed  Google Scholar 

  2. Lee AW, Ng WT, Chan YH, Sze H, Chan C, Lam TH. The battle against nasopharyngeal cancer. Radiother Oncol. 2012;104:272–8.

    Article  PubMed  Google Scholar 

  3. O’Neil JD, Owen TJ, Wood VH, Date KL, Valentine R, Chukwuma MB, et al. Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. J Gen Virol. 2008;89:2833–42.

    Article  PubMed  CAS  Google Scholar 

  4. Horikawa T, Yoshizaki T, Kondo S, Furukawa M, Kaizaki Y, Pagano JS. Epstein-Barr virus latent membrane protein 1 induces snail and epithelial–mesenchymal transition in metastatic nasopharyngeal carcinoma. Br J Cancer. 2011;104:1160–7.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  5. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12:421–9.

    Article  PubMed  Google Scholar 

  6. Li L, Wu J, Sima X, Bai P, Deng W, Deng X, et al. Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma. Tumor Biol. 2013;34:1919–23.

    Article  CAS  Google Scholar 

  7. Hu S, Zhou G, Zhang L, Jiang H, **ao M. The effects of functional polymorphisms in the TGFbeta1 gene on nasopharyngeal carcinoma susceptibility. Otolaryngol Head Neck Surg. 2012;146:579–84.

    Article  PubMed  Google Scholar 

  8. Qin HD, Shugart YY, Bei JX, Pan QH, Chen L, Feng QS, et al. Comprehensive pathway-based association study of DNA repair gene variants and the risk of nasopharyngeal carcinoma. Cancer Res. 2011;71:3000–8.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  9. Ben Chaaben A, Busson M, Douik H, Boukouaci W, Mamoghli T, Chaouch L, et al. Association of IL-12p40 +1188 A/C polymorphism with nasopharyngeal cancer risk and tumor extension. Tissue Antigens. 2011;78:148–51.

    Article  PubMed  CAS  Google Scholar 

  10. McDermott AL, Dutt SN, Watkinson JC. The etiology of nasopharyngeal carcinoma. Clin Otolaryngol Allied Sci. 2001;26:82–92.

    Article  PubMed  CAS  Google Scholar 

  11. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997;88:323–31.

    Article  PubMed  CAS  Google Scholar 

  12. Goodsell DS. The molecular perspective: p53 tumor suppressor. Oncologist. 1999;4:138–9.

    PubMed  CAS  Google Scholar 

  13. Hickman ES, Helin K. The p53 tumor suppressor protein. Biotechnol Genet Eng Rev. 2000;17:179–211.

    Article  PubMed  CAS  Google Scholar 

  14. Hou J, Jiang Y, Tang W, Jia S. p53 codon 72 polymorphism and breast cancer risk: a meta-analysis. Exp Ther Med. 2013;5:1397–402.

    PubMed Central  PubMed  CAS  Google Scholar 

  15. Wang S, Chen L, Zhao Q, Rong H, Wang M, Gong W, et al. Effect of TP53 codon 72 and MDM2 SNP309 polymorphisms on survival of gastric cancer among patients who receiving 5-fluorouracil-based postoperative adjuvant chemotherapy. Cancer Chemother Pharmacol. 2013;71:1073–82.

    Article  PubMed  CAS  Google Scholar 

  16. Szymanska K, Chen JG, Cui Y, Gong YY, Turner PC, Villar S, et al. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China. Cancer Epidemiol Biomarkers Prev. 2009;18:1638–43.

    Article  PubMed  CAS  Google Scholar 

  17. Szymanska K, Hainaut P. TP53 and mutations in human cancer. Acta Biochim Pol. 2003;50:231–8.

    PubMed  CAS  Google Scholar 

  18. Yang Z, Nie S, Zhu H, Wu X, Jia S, Luo Y, et al. Association of p53 Arg72Pro polymorphism with bladder cancer: a meta-analysis. Gene. 2013;512:408–13.

    Article  PubMed  CAS  Google Scholar 

  19. Tang W, Zhou X, Nie S, Yang Z, Zhu H, Wu X, et al. Association of p53 Arg72Pro polymorphism with gastric cancer: a meta-analysis. Biomarkers. 2012;17:597–603.

    Article  PubMed  CAS  Google Scholar 

  20. Tang W, He X, Chan Y, Luo Y. Lack of association between p53 codon 72 polymorphism and endometrial cancer: a meta-analysis. Cancer Epidemiol. 2012;36:e153–7.

    Article  PubMed  CAS  Google Scholar 

  21. Hadhri-Guiga B, Toumi N, Khabir A, Sellami-Boudawara T, Ghorbel A, Daoud J, et al. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia. Cancer Genet Cytogenet. 2007;178:89–93.

    Article  PubMed  CAS  Google Scholar 

  22. Sousa H, Santos AM, Catarino R, Pinto D, Vasconcelos A, Lopes C, et al. Linkage of TP53 codon 72 pro/pro genotype as predictive factor for nasopharyngeal carcinoma development. Eur J Cancer Prev. 2006;15:362–6.

    Article  PubMed  CAS  Google Scholar 

  23. Tiwawech D, Srivatanakul P, Karaluk A, Ishida T. The p53 codon 72 polymorphism in Thai nasopharyngeal carcinoma. Cancer Lett. 2003;198:69–75.

    Article  PubMed  CAS  Google Scholar 

  24. Tsai MH, Lin CD, Hsieh YY, Chang FC, Tsai FJ, Chen WC, et al. Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma. Laryngoscope. 2002;112:116–9.

    Article  PubMed  CAS  Google Scholar 

  25. **ao M, Zhang L, Zhu X, Huang J, Jiang H, Hu S, et al. Genetic polymorphisms of MDM2 and TP53 genes are associated with risk of nasopharyngeal carcinoma in a Chinese population. BMC Cancer. 2010;10:147.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  26. Yung WC, Ng MH, Sham JS, Choy DT. p53 codon 72 polymorphism in nasopharyngeal carcinoma. Cancer Genet Cytogenet. 1997;93:181–2.

    Article  PubMed  CAS  Google Scholar 

  27. Cochran WG. The comparison of percentages in matched samples. Biometrika. 1950;37:256–66.

    Article  PubMed  CAS  Google Scholar 

  28. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    PubMed  CAS  Google Scholar 

  30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  PubMed  CAS  Google Scholar 

  31. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  32. Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316:469. author reply 470–461.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  33. Huang X, Cao Z, Zhang Z, Yang Y, Wang J, Fang D. No association between vitamin D receptor gene polymorphisms and nasopharyngeal carcinoma in a Chinese Han population. Biosci Trends. 2011;5:99–103.

    Article  PubMed  CAS  Google Scholar 

  34. Zheng J, Liu B, Zhang L, Jiang L, Huang B, You Y, et al. The protective role of polymorphism MKK4-1304 T > G in nasopharyngeal carcinoma is modulated by Epstein-Barr virus infection status. Int J Cancer. 2012;130:1981–90.

    Article  PubMed  CAS  Google Scholar 

  35. Harms K, Nozell S, Chen X. The common and distinct target genes of the p53 family transcription factors. Cell Mol Life Sci. 2004;61:822–42.

    Article  PubMed  CAS  Google Scholar 

  36. Mills AA. p53: link to the past, bridge to the future. Genes Dev. 2005;19:2091–9.

    Article  PubMed  CAS  Google Scholar 

  37. Lu Y, Huang GL, Pu XX, He YX, Li BB, Liu XY, et al. Association between PIN1 promoter polymorphisms and risk of nasopharyngeal carcinoma. Mol Biol Rep. 2013;40:3777–82.

    Article  PubMed  CAS  Google Scholar 

  38. **e L, Liang XN, Deng Y, Qin X, Li S. TNF-alpha-308G/A polymorphisms and nasopharyngeal cancer risk: a meta-analysis. Eur Arch Otorhinolaryngol. 2013;270:1667–72.

    Article  PubMed  Google Scholar 

  39. Wei Y, Zhou T, Lin H, Sun M, Wang D, Li H, et al. Significant associations between GSTM1/GSTT1 polymorphisms and nasopharyngeal cancer risk. Tumor Biol. 2013;34:887–94.

    Article  CAS  Google Scholar 

  40. Nie Y, Sun Y, Wang Y, Liu C, Zhao C, Luo B. Epstein-Barr virus gene polymorphism in different parts of the same nasopharyngeal carcinoma patient. Arch Virol. 2013;158:1031–7.

    Article  PubMed  CAS  Google Scholar 

  41. Cheng YJ, Wolkenhauer M, Bumbu GG, Gutmann JS. A facile route to reassemble titania nanoparticles into ordered chain-like networks on substrate. Macromol Rapid Commun. 2012;33:218–24.

    Article  PubMed  CAS  Google Scholar 

  42. Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis RC. Diet, nutrition, and the prevention of cancer. Public Health Nutr. 2004;7:187–200.

    Article  PubMed  Google Scholar 

  43. Nayak MS, Yang JM, Hait WN. Effect of a single nucleotide polymorphism in the murine double minute 2 promoter (SNP309) on the sensitivity to topoisomerase II-targeting drugs. Cancer Res. 2007;67:5831–9.

    Article  PubMed  CAS  Google Scholar 

  44. Boersma BJ, Howe TM, Goodman JE, Yfantis HG, Lee DH, Chanock SJ, et al. Association of breast cancer outcome with status of p53 and MDM2 SNP309. J Natl Cancer Inst. 2006;98:911–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology Head and Neck Surgery, People’s Hospital of Taizhou, Taizhou, 225300, Jiangsu, China

    Kemin Cai, Yu Wang, **aojun Zhao & Xueli Bao

Authors
  1. Kemin Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. **aojun Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xueli Bao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Kemin Cai or Xueli Bao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cai, K., Wang, Y., Zhao, X. et al. Association between the P53 codon 72 polymorphism and nasopharyngeal cancer risk. Tumor Biol. 35, 1891–1897 (2014). https://doi.org/10.1007/s13277-013-1254-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1254-5

Keywords

Search

Navigation